17-oxogenic steroids have been analysed by gas chromatography (GC) with capillary column and flame ionization detector. The best separation of steroid products was gained after ethyloxime-trimethylsilyl ether formation. The value of the GC method as a screening procedure for patients with suspected adrenal disease is illustrated in selected cases where the diagnosis was equivocal from data derived by RIA analysis of plasma steroids.
In 1983 the Association of Clinical Biochemists Working Party for Clinical Laboratory Investigations' recommended that urinary 17-oxogenic and 17-oxosteroids should be deleted from the laboratory repertoire of investigations. In the diagnosis of adrenal disease we are in agreement that the assay of 17-oxogenic steroids with colorimetric end-point has been superceded by methods with greater precision and specificity. A number of laboratories, however, continue to operate modifications of this assay where oxidation products are determined by gas chromatography (GC). The value of such assays is reviewed in relation to the efficient differential diagnosis of steroid disorders using the available techniques. A variant of this approach with general application is described.
There remains a requirement for specialist laboratories to offer diagnostic procedures to cover the rarer steroid disorders (IIPhydroxylase deficiency, 3p-hydroxysteroid dehydrogenase deficiency, virilizing tumours") and some defects for which there are as yet few plasma data (pseudohypoaldosteronism and aldosterone biosynthetic defects"), In this context capillary column GC separation of steroids in urine" (profile analysis) has proved highly effective. This is particularly so in newborn infants when differences in steroid metabolism, lack of reference ranges and difficulties in repeated blood sampling make diagnosis less precise than in later life.
In an attempt to simplify the full GC profile 338 analysis" which requires steroid extraction, enzyme hydrolysis, further extraction and derivative formation we have devised a capillary column GC separation of the oxidation products formed in the oxogenic steroid method. Recovery experiments and case studies of common and rarer steroid disorders are reported. The method is essentially that used for many years 5 ,6.7 to assess steroid production by analysis of structurally related groups by colorimetric assay, i.e. 17-oxosteroids and 17-oxogenic steroids. When these tests were considered obsolete the Working Party did not apparently consider applications of the-17-oxogenic method where products are determined by GC. Such an approach is still used with effect in several laboratories to give information on cortisol derivatives, cortisol precursors and adrenal androgens.
PRINCIPLES OF THE 17-0XOGENIC METHOD WITH GAS CHROMATOGRAPffiC DETECTION
Steroid hormones are inactivated principally in the liver by saturation of the A-ring (to give tetrahydro metabolites) and by reduction of the side chain. These products are excreted in urine usually as conjugates with glucuronic acid. Table  I summarizes the relationship between the principal metabolites found in urine and the biosynthetic origin of the hormones elaborated by the adrenal glands.
In the 17-oxogenic method, metabolites of the three main classes of steroids (androgens, mineralocorticoids and glucocorticoids) present in urine are reduced with sodium borohydride followed by oxidation with sodium periodate, The sodium borohydride reduces carbonyl groups on the steroid nuclei to hydroxyl groups and sodium periodate cleaves the carbon bond present between two adjacent hydroxyl groups (glycol function) if such a structure is present in the molecule at C-20 and C-21 or C-17 and C-20. Treatment of the steroid conjugates with sodium borohydride and sodium periodate reduces the glucuronic acid groups to formates. Free steroids are liberated by hydrolysis of the formates with sodium hydroxide. Makin 7 analysed the 17-oxogenic products as formate ester derivatives on a gas chromatograph with a packed column. Others'" have used trimethylsilyl ether derivatives which gives separation of most steroids but the possibility remains that some steroids are not completely resolved. With the advent of capillary columns the individual steroid products should be resolved. This should improve specificity in identification and hence provide a more general application of the 17-oxogenic method for the diagnosis of steroid disease states.
METHOD
A 5 mL portion of a 24 h urine collection was adjusted to pH 7 by the addition of I M NaOH (1 mL). One drop of octanol was added to prevent frothing when next adding 10% w/v sodium borohydride solution in 0·1 M NaOH (I mL). The reaction with borohydride was allowed to proceed for 45 min at 6D-65°C after which 25% vlv acetic acid (I mL) was added to decompose the excess borohydride. Complete decomposition was achieved by incubation at 60-65°C for Zrnin." Ten per cent w/v aqueous sodium meta-periodate (6 mL) was then added and allowed to react for l Omin at 60-65°C. This was followed by the addition of I mL of 5 M NaOH to hydrolyse the steroid formates. The free steroids were extracted into chloroform by vigorously shaking the aqueous solution with IS mL of solvent for I min. The phases were separated by centrifugation at 3000 g for 15 min. The upper aqueous layer was removed with a pipette and discarded, the organic layer was dried at 4Q°C on a rotary evaporator under vacuum. The dry extract was dissolved in about I mL ethanol.
Preparation of derivatives for GC
The steroid extracts were derivatized to ensure their thermal stability, volatility and hence suitability for analysis on GC and GC-MS at fairly high temperatures. An aliquot of an internal standard mixture containing 10Jlg each of 5ot-androstane-3ot,17ot-diol (A), stigmasterol (S) and cholesteryl butyrate (C), was added to all extracts. The solvents of the extract and internal standards (A, S, C) were evaporated to dryness prior to chemical derivatization of the steroids.
Oxime formation (derivatization of carbonyl groups) Two hundred microgrammes of dry pyridine (AnalaR grade, BDH Chemicals, Poole, UKredistilled over sodium hydroxide) containing 2% w/v methoxyamine-hydrochloride (MO-HCI) (Pierce Chemicals, Life Sciences Laboratories, Luton, UK) was added to the steroid extract. This was sonicated to ensure good mixing and to dissolve the steroids in the MO-HCl/pyridine solution. The reaction was allowed to proceed at 60°C for I h.
Ethoxime derivatives were formed in the same way as methoxime derivatives. Thus to the dried steroid extract, 200 JlL of 2% w/v solution of ethoxyamine hydrochloride (pierce Chemicals) solution in pyridine was added and reaction allowed to proceed at 60°C for I h.
R.
Trimethylsilyl ether formation (derivatization of the hydroxyl groups) After oxime formation hydroxyl groups were derivatized by addition of 200 JlL of hexamethyldisilazane (HMDS) and I drop of trimethylchlorosilane (TMCS). The reaction was allowed to proceed at room temperature. After 4 h the reaction mixture was dried under nitrogen and immediately 1 mL of redistilled cyclohexane was added. The mixture was sonicated to resuspend the solid products which were packed again by centrifugation at 3000 g for 10 min. The supernatant was transferred to a screwcap vial and the derivative was concentrated to 250 JlL by evaporation of the solvent. The retention times of reference steroids in the GC analysis were obtained by co-injecting onto the gas chromatograph about 50 ng of each derivative with a similar mass of a solution containing a mixture of even numbered n-alkanes (C 24 -C]4)' GC retention times were determined relative to the nearest alkanes and expressed as methylene units (MU, e.g. C 26 is 26·00 MU).
Gas chromatography
The excretion rates of each steroid in urine were determined after correction for individual variation in GC response. Response factors for individual components were measured by relating their peak heights to heights of a line joining the peaks of known amounts of added 51Xandrostane-Sa, 171X-diol (A), stigmasterol (S) and cholesteryl butyrate (C). Most standard steroids gave a peak reaching the line joining A and C when used in same amounts as internal standards. Some steroids (particularly those with a carbonyl group at C-II) gave a poor response. The identity of steroids was verified by separate analysis with GC coupled to a mass spectrometer (Mass Selective Detector, Hewlett-Packard, Winnersh, UK).
RESULTS
As MO-TMS derivatives the androstanediols were not resolved from androsterone and aetiocholanolone. Good separations of the 17oxogenic products were obtained using the EO-TMS derivatives and this was used for the evaluation of the method with clinical samples.
In order to evaluate the recovery of steroids in the method, varying amounts of androsterone a~d tetrahydrocortisone were added to equal ahquots of a 24 h urine collection. 51X-androstane-Je, 17fJ-diol and II fJ-hydroxyaetiocholanolone were measured in the samples taken through the method. The measured response for 51Xandrostane-Je, 17fJ-diol was 0'89x + 1·6 relative to the added androsterone. The recovery of IlfJhydroxyaetiocholanolone was 96% after correction for the GC response of this derivatized steroid. Distilled water treated as a urine sample gave no significant peaks to interfere with the proposed procedures.
The GC profile of 17-oxogenic products from u~ne of a normal adult man (Fig. I) and aetiocholanolone) and l Iji-hydroxyaetiocholanolone, IlfJ-hydroxyandrosterone (peaks 9 and 6) from cortisol metabolites. The amounts determined by this method correlated with the daily excretion rates of 1-2 mg for androgen and cortisol metabolites measured in the full GC profile method. Repeated analysis of the same sample gave variation in the steroid excretion rates comparable with the full steroid profile analysis (CV around 20%). The method was optimized with respect to the sample size and internal standard concentrations so that the peak heights for the urine steroids were smaller than the peaks for the internal standards. A peak for pregnanediol (No.7) was recognizable in the profile. Several determinations of pregnanediol Oxogenic steriod GC 341 excretion were made in two normal women at intervals during the menstrual cycle. The formation of a corpus luteum was confirmed with pregnanediol excretion greater than I mg/day, It has to be said, however, that the measurement of progesterone in serum or saliva by RIA gives the necessary information at less cost. In many of the patients samples analysed the major peaks were larger than the internal standards-reflecting the high excretion of metabolites from the hyperplastic adrenals due to Cushings syndrome or in response to ACTH stimulation due to enzyme blockade. The 17oxogenic profile in Cushings syndrome is dominated by a large peak for IlfJ-hydroxyaetiocholanolone.
CASE HISTORIES
Case I: This patient presented at age 56 years complaining of muscle pain. On examination the patient had male genitalia without testes. Chromsome analysis was 64XX. The serum testosterone was 28 nmol/L (adult concentration for men) and the 170(-hydroxyprogesterone was 1100 nmol/L (normal range < 15nmoI/L). The early medical history of this patient had been presented to the Royal Society of Medicine in 1945. 10 The oxogenic profile showed increased amounts of 50(-and 5fJ-androstane-30(, 17fJ-diol from the increased androgens in the urine. The major peak in the profile was for aetiocholanolone-the oxidation product of 170(hydroxypregnanolone and pregnanetrio!. A large peak was also seen for l l-hydroxyaetiocholanolone formed from l l-oxo-pregnanetriol-the urine metabolite of 21-deoxycortiso!. These data supported a diagnosis of congenital adrenal hyperplasia (CAH) due to 21hydroxylase deficiency.
Case 2: This case was of a boy who presented at the age of 3 years 9 months with a 4 month history of development of secondary sexual characteristics. On examination his bone age was advanced to 10 years, his penis was of adult proportions and pubic hair was present. There were a number of difficulties in interpretation of laboratory data." In the oxogenic profile there were raised androgen metabolites and products of cortisol precursors. The absence of a peak for l l-hydroxy-aetiocholanolone distinguished the profile (Fig. 1) from that of 21-hydroxylase deficiency so that the profile supported a diagnosis of CAH due to IlfJ-hydroxylase deficiency. In the case of a newborn infant with this enzyme block (case 3) we were able to confirm the high excretion of a metabolite presumed to be 61Xhydroxy-tetrahydro-II-deoxycortisol by finding a peak in the oxogenic profile which corresponded in GC retention time and mass spectrum with a reference sample of synthetic 61X-hydroxyaetiocholanolone." When a patient with Cushings syndrome (case 4) was treated with metyrapone a pattern of oxogenic steroid products similar to case I was seen confirming the action of the lIP-hydroxylase inhibitor.
Case 5 was admitted into hospital for the investigation of hypokalaernie alkalosis and hypertension. Her medical history!' included investigations for primary amenorrhoea and hypertension at the age of 18 years. The oxogenic profile (Fig.  2) had no peaks for androstanediols, androsterone or aetiocholanolone but showed raised urine excretion of an unusual series of products shown to be derived from urine metabolites of pregnenediol and pregnane-31X,llp,20p-triol. In addition the presence of a large peak for 17formyl-Sji-androstane-S«, II P-diol from 5p-tetrahydrocorticosterone supports the diagnosis of 171X-hydroxylase deficiency.
Case 6 presented at the age of 21 years with primary amenorrhoea and failure of breast development. Chromosome analysis showed XY karyotype and the serum testosterone was 25·6 nmol/L." A GC profile analysis of intact (0) urine steroids showed an increase in the ratio of aetiocholanolone (5P) to androsterone (51X) which supports the diagnosis of 51X-reductase deficiency. This was confirmed with a reduced enzyme activity in genital skin. In the oxogenic steroid profile (Fig. 2 ) of this patient the increased 5P to 51X metabolite ratio was apparent from the androstanediol peaks.
DISCUSSION
The serum concentrations of steroid hormones can now be measured simply and precisely by using radioimmunoassay (RIA) though few laboratories use, or have easy access to, methods outside those most commonly determined-testosterone, progesterone, 171X-hydroxyproges terone, cortisol, oestradiol and dehydroepiandrosterone sulphate (DHA-S). When used in conjunction with trophic hormone determinations and with dynamic tests of endocrine function these assays can cover the diagnostic requirements for a wide range of clinical situations.' For the diagnosis of certain disorders, e.g. 51X-reductase deficiency it is necessary to measure the plasma concentrations of two or more hormones and to establish ratios of the steroids. In the neonatal period particular attention should be given to the specificity of laboratory methods since the function of the definitive adrenal zone is Some examples of rarer steroid problems have been summarized here. The method has not been tested extensively for diagnosis of adrenal diseases in the newborn period. It is expected that steroid sulphates produced by the fetal adrenal cortex may be partially hydrolysed by the chemical steps in producing the 17 oxogenic products. In many cases steroid metabolism in the neonate is different from the adult with a preference for hydroxylation over conjugate formation'Y" therefore a different set of oxogenic steroids is to be expected. Thus in the case of llfJ hydroxylase deficiency, 6fJ-hydroxyaetiocholanolone would be a useful marker for the defect in a newborn infant." In these cases a full steroid profile is still probably the best expedient. The markers for adrenal disease are different in the newborn period-thus 17fJ hydroxy pregnanolone and 3fJ, l5oc, 17fJ-trihydroxy-5fJ-pregnan-20 one are more important metabolites of l7oc-hydroxy progesterone than in the adult where pregnanetriol together with ll-oxo-pregnanetriol (from 21deoxycortisol) are prominent metabolites.
The metyrapone test is useful for the differential diagnosis of Cushings syndrome but care is required in selecting analytes which give appropriate data. The cross reaction of 11-dominated by the contribution from the fetal adrenal zone secreting DHA-sulphate and pregnenolone derivatives.
The gas liquid chromatography separation of 17-oxosteroids derived from urinary 17-oxogenic steroids by side-chain cleavage with periodate or bismuthate is well documented7.1s-17 and is still used in some laboratories. The method described is simple-s-requiring equipment and reagents available in many laboratories. The use of capillary columns has become much easier in recent years with the introduction of fused silica columns (instead of glass) and the availability of low dead volume couplings and high temperature graphite seals. An automated solid injection system enables several samples to be processed without continuous attention although this is not essential. Other techniques using the on-column injector, split/splitless injector or falling needle are quite acceptable.
In temperature programmed GC the retention characteristics of the necessary steroid products need to be standardized against hydrocarbons (methylene units). The retention times are reproducible as is the overall pattern of metabolites obtained in normal and specific pathological situations. Mass spectrometry is not essential for a general service. If necessary the derivative can be sent to a specialized laboratory with this equipment and experience.
The major steroids in the urine of a normal adult are androsterone, aetiocholanolone, tetrahydrocortisone, tetrahydocortisol and 5fJtetrahydocortisol. These represent the excretory products of androgens and cortisol metabolites. The present study, and previous reports.P:" have shown that, using GC to separate steroids before flame ionization detection, the 17-oxogenic products from these metabolites can be recognized and quantified in urine. The identities of steroids by GC retention time was not always possible when separating steroid formate esters by packed column Gc. 16, 17 Confirmation of the derivatives by mass spectrometry was not available at the time of these early studies. The electron impact mass spectra of clinically important androgens as their formate derivatives were not published until 1979. 16 Trimethylsilyl ether derivatization is a popular means of stabilizing steroids because it permits the high temperature gas chromatographic analysis of the range of steroid metabolites and gives mass spectra which are easier to interpret than for other derivatives. IS In order to exclude interference from drugs it is helpful to check unusual spectra against a mass 17- deoxycortisol in RIA methods for cortisol is particularly relevant (this is also seen from the problems in reaching a diagnosis of liP hydroxylase deficiency in case 2).11 The 17 oxogenic method has a distinct advantage in this respect.
The II oxygenated and II-deoxosteroids are quantified separately. Following metyrapone an increase in the l l-deoxy steroid excretion compared with that of II hydroxysteroids in the basal sample is usually taken as evidence to support pituitary-dependent Cushing's syndrome. Similar data are gained by measuring plasma II-deoxycortisol concentrations before and after the metyrapone. When the measurement of cortisol in serum is likely to be difficult in the presence of l l-deoxycortisol interference can be readily overcome by solvent partition.
In conclusion, we suggest that the 17-oxogenic method with gas chromatography for separation of the products has a place in certain clinical laboratories.
